Sanford Guide to Antimicrobial Therapy

Cover
......Page 1
Contents
......Page 2
Abbreviations
......Page 3
TABLE 1 - 
CLINICAL APPROACH TO INITIAL CHOICE OF ANTIMICROBIAL THERAPY......Page 5
TABLE 2 - 
RECOMMENDED ANTIMICROBIAL AGENTS AGAINST SELECTED BACTERIA......Page 63
TABLE 3 - 
SUGGESTED DURATION OF ANTIBIOTIC THERAPY IN IMMUNOCOMPETENT PATIENTS......Page 66
TABLE 4 
COMPARISON OF ANTIBACTERIAL SPECTRA......Page 67
TABLE 5 
TREATMENT OPTIONS FOR SELECTED HIGHLY RESISTANT BACTERIA......Page 73
TABLE 6 – SUGGESTED MANAGEMENT OF SUSPECTED OR CULTURE-POSITIVE COMMUNITY-ASSOCIATED
......Page 75
TABLE 7
 -  METHODS FOR DRUG DESENSITIZATION......Page 77
TABLE 8 – RISK CATEGORIES OF ANTIMICROBICS IN PREGNANCY
......Page 78
TABLE 9 -  SELECTED PHARMACOLOGIC FEATURES OF ANTIMICROBIAL AGENTS......Page 79
TABLE 10A-B - 
SELECTED ANTIBACTERIAL AGENTS—ADVERSE REACTIONS—OVERVIEW......Page 85
TABLE 10C - 
ANTIBIOTIC DOSAGE  AND SIDE-EFFECTS......Page 90
TABLE 10D - 
AMINOGLYCOSIDE ONCE-DAILY AND MULTIPLE DAILY DOSING REGIMENS......Page 98
TABLE 11A
 -  TREATMENT OF FUNGAL INFECTIONS—ANTIMICROBIAL AGENTS OF CHOICE......Page 99
TABLE 11B – ANTIFUNGAL DRUGS: DOSAGE, ADVERSE EFFECTS, COMMENTS
......Page 113
TABLE 11C - 
AT A GLANCE SUMMARY OF SUGGESTED ANTIFUNGAL DRUGS AGAINST TREATABLE PATHOGENIC FUNGI......Page 116
TABLE 12A - 
TREATMENT OF MYCOBACTERIAL INFECTIONS......Page 117
TABLE 12B – DOSAGE AND ADVERSE EFFECTS OF ANTIMYCOBACTERIAL DRUGS
......Page 127
TABLE 13A - 
TREATMENT OF PARASITIC INFECTIONS......Page 130
TABLE 13B – DOSAGE AND SELECTED ADVERSE EFFECTS OF ANTIPARASITIC DRUGS
......Page 140
TABLE 14A – ANTIVIRAL THERAPY (NON-HIV)
......Page 144
TABLE 14B – ANTIVIRAL DRUGS (NON-HIV)
......Page 156
TABLE 14C – AT A GLANCE SUMMARY OF SUGGESTED ANTIVIRAL AGENTS AGAINST TREATABLE PATHOGENIC VIRUSES
......Page 161
TABLE 14D – ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE ADULTS (HIV/AIDS
......Page 162
TABLE 14E– ANTIRETROVIRAL DRUGS AND ADVERSE EFFECTS (HIV/AIDS)
......Page 172
TABLE 15A – ANTIMICROBIAL PROPHYLAXIS FOR SELECTED BACTERIAL INFECTIONS
......Page 175
TABLE 16 – PEDIATRIC DOSAGES OF SELECTED ANTIBACTERIAL AGENTS
......Page 186
TABLE 17A – DOSAGE OF ANTIMICROBIAL DRUGS IN ADULT PATIENTS WITH RENAL IMPAIRMENT
......Page 187
TABLE 19 – TREATMENT OF CAPD PERITONITIS IN ADULTS
......Page 195
TABLE 20A – RECOMMENDED CHILDHOOD & ADOLESCENT IMMUNIZATION SCHEDULE
IN THE UNITED STATES......Page 196
TABLE 20B - ADULT IMMUNIZATION IN THE UNITED STATES
......Page 197
TABLE 20C – ANTI-TETANUS PROPHYLAXIS, WOUND CLASSIFICATION, IMMUNIZATION
......Page 199
TABLE 20D – RABIES POST-EXPOSURE PROPHYLAXIS
......Page 200
TABLE 21 SELECTED DIRECTORY OF RESOURCES......Page 201
TABLE 22A – ANTI-INFECTIVE DRUG-DRUG INTERACTIONS
......Page 202
TABLE 22B – DRUG-DRUG INTERACTIONS BETWEEN NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) AND PROTEASE INHIBITORS
......Page 209
TABLE 23 – LIST OF GENERIC AND COMMON TRADE NAMES
......Page 210
Index......Page 212